Scott Friedman

Scott Friedman is Chief of the Division of Liver Diseases and Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai, New York, and was President of the American Association for the Study of Liver Diseases (AASLD) in 2009. Dr. Friedman is one of the foremost leaders in the field of liver fibrosis, having been the first to isolate and characterize the causative cell type. He contributes a wealth of experience with emerging diagnostic and therapeutic approaches in serious liver disease. Dr. Friedman received his MD degree from Mount Sinai and completed his training at Beth Israel Hospital, Boston, and the University of California, San Francisco.